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in situ differentiation of endogenous neural stem cells (NSC) represents a potential
therapeutic strategy to replace injured neuronal cells and to treat
neurodegenerative diseases. Nevertheless, no work based on this approach has yet
reached the clinical phase. The lack of NSC-targeting molecules primarily promotes
the development of non-selective systems with limited effects on NSC
differentiation. The aim of our work was to produce a drug delivery system able to
selectively target endogenous NSC. The peptide NFL-TBS.40-63 (NFL) shows
specific interactions with brain NSC, where it affects their properties and induces
their differentiation [1]. Consequently, we produced an NFL-based drug delivery
system to target those cells. The peptide was adsorbed on DiD-labeled lipid
nanocapsules (LNC, NFL-LNC) and characterized by dynamic light scattering. NFL-
LNC targeting efficiency was evaluated on brain and spinal cord NSC. NFL-LNC
were incubated with primary NSC cultures, in vitro, and injected either in adult rat's
brain or spinal cord, in vivo. The determination of the targeting efficiency was
performed by FACS for in vitro experiments, and by immunohistochemistry for in
vivo study. Both in vitro and in vivo results show that NFL-LNC targeted brain NSC
while they showed no affinity for spinal cord NSC [2]. While we are currently
investigating the mechanisms involved in the preferential interactions of NFL-LNC
with brain NSC, these data show that NFL-LNC is a promising therapeutic tool to
selectively deliver bioactive molecules and to induce in situ NSC differentiation.
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